abrdn plc Sells 52,940 Shares of Integer Holdings Co. (NYSE:ITGR)

abrdn plc decreased its stake in shares of Integer Holdings Co. (NYSE:ITGR) by 18.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 240,301 shares of the medical equipment provider’s stock after selling 52,940 shares during the period. abrdn plc owned approximately 0.72% of Integer worth $32,099,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the stock. Laurus Investment Counsel Inc. bought a new stake in shares of Integer during the 4th quarter valued at about $5,422,000. R Squared Ltd purchased a new position in Integer during the 4th quarter valued at about $44,000. KBC Group NV lifted its position in Integer by 83.3% during the 4th quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider’s stock valued at $212,000 after acquiring an additional 726 shares during the period. Blue Trust Inc. lifted its position in Integer by 4.4% during the 4th quarter. Blue Trust Inc. now owns 1,689 shares of the medical equipment provider’s stock valued at $220,000 after acquiring an additional 71 shares during the period. Finally, Tributary Capital Management LLC lifted its position in Integer by 0.8% during the 4th quarter. Tributary Capital Management LLC now owns 287,525 shares of the medical equipment provider’s stock valued at $38,103,000 after acquiring an additional 2,289 shares during the period. Institutional investors own 99.29% of the company’s stock.

Integer Stock Up 2.1 %

ITGR opened at $142.37 on Thursday. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67. The firm has a 50 day moving average price of $137.91 and a 200-day moving average price of $130.80. Integer Holdings Co. has a twelve month low of $94.56 and a twelve month high of $146.36. The stock has a market capitalization of $4.78 billion, a price-to-earnings ratio of 43.94, a PEG ratio of 1.81 and a beta of 1.13.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Citigroup lifted their price target on shares of Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research report on Wednesday, December 11th. Truist Financial lifted their target price on shares of Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Piper Sandler reaffirmed an “overweight” rating and issued a $140.00 target price (up from $125.00) on shares of Integer in a report on Friday, October 25th. Benchmark lifted their target price on shares of Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, October 21st. Finally, KeyCorp lifted their target price on shares of Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. One research analyst has rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat, Integer presently has an average rating of “Moderate Buy” and a consensus price target of $146.56.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.